Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Bristol Myers Squibb Company (BMY) had Free Cash Flow of $11.24B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$12.22B |
|
$2.20B |
|
$3.44B |
|
$8.79B |
|
$9.11B |
|
$3.11B |
|
-- |
|
$3.11B |
|
$3.11B |
|
$2.19B |
|
$2.19B |
|
$2.19B |
|
$2.19B |
|
$3.11B |
|
$4.12B |
|
2.04B |
|
2.04B |
|
$1.08 |
|
$1.08 |
|
| Balance Sheet Financials | |
$35.63B |
|
$7.35B |
|
$61.26B |
|
$96.89B |
|
$28.14B |
|
$44.47B |
|
$50.15B |
|
$78.29B |
|
$18.60B |
|
$-23.61B |
|
$18.60B |
|
2.04B |
|
| Cash Flow Statement Financials | |
$12.18B |
|
$-2.67B |
|
$-4.32B |
|
$10.35B |
|
$15.73B |
|
$5.38B |
|
$420.00M |
|
$-3.78B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
0.71 |
|
2.63 |
|
71.89% |
|
25.48% |
|
25.48% |
|
-- |
|
25.48% |
|
18.01% |
|
|
Free Cash Flow |
$11.24B |
-- |
|
-- |
|
-- |
|
0.13 |
|
1.25 |
|
1.07 |
|
84.11 |
|
11.80% |
|
-9.30% |
|
2.27% |
|
3.48% |
|
$9.14 |
|
$5.51 |
|
$5.97 |
|